Corneal fine needle diathermy with adjuvant bevacizumab to treat corneal neovascularization in children

Cornea

Volumn 34, Issue 7, 2015, Pages 773-777

  Elbaz, Uri ^a   Mireskandari, Kamiar ^a   Shen, Carl ^a   Ali, Asim ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

bevacizumab; corneal neovascularization; fine needle diathermy

Indexed keywords

BEVACIZUMAB; FLUOROMETHOLONE; MOXIFLOXACIN; PREDNISOLONE; ANGIOGENESIS INHIBITOR; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADJUVANT THERAPY; ADOLESCENT; ANESTHESIA; ARTICLE; BRAIN TUMOR; CHILD; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONSERVATIVE TREATMENT; CORNEA EDEMA; CORNEA NEOVASCULARIZATION; CORNEA TRANSPLANTATION; CORNEA ULCER; DIATHERMY; FINE NEEDLE DIATHERMY; FOLLOW UP; HERPES SIMPLEX KERATITIS; HUMAN; KERATOCONJUNCTIVITIS; KERATOPLASTY; LIPID STORAGE; MEDICAL RECORD; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCAR; SLIT LAMP; TERATOMA; VISUAL ACUITY; ANTAGONISTS AND INHIBITORS; CONJUNCTIVA; CORNEA STROMA; CORNEAL NEOVASCULARIZATION; DRUG EFFECTS; ELECTROCOAGULATION; FEMALE; INTRAOCULAR DRUG ADMINISTRATION; MALE; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; PROCEDURES; TREATMENT OUTCOME;

ADOLESCENT; ANGIOGENESIS INHIBITORS; BEVACIZUMAB; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CONJUNCTIVA; CORNEAL NEOVASCULARIZATION; CORNEAL STROMA; ELECTROCOAGULATION; FEMALE; HUMANS; INJECTIONS, INTRAOCULAR; MALE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84932183236     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0000000000000419     Document Type: Article

References (24)

1. Hamada S, Khan I, Denniston AK, et al. Childhood blepharokeratocon-junctivitis: characterising a severe phenotype in white adolescents. Br J Ophthalmol. 2012;96:949-955.
2. Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol. 2003;3:879-889.
3. Niederkorn JY. Immune privilege and immune regulation in the eye. Adv Immunol. 1990;48:191-226.
4. Chang JH, Gabison EE, Kato T, et al. Corneal neovascularization. Curr Opin Ophthalmol. 2001;12:242-249.
5. Harvey PT, Cherry PM. Indomethacin v. dexamethasone in the suppression of corneal neovascularization. Can J Ophthalmol. 1983;18: 293-295.
6. Nirankari VS, Baer JC. Corneal argon laser photocoagulation for neovascularization in penetrating keratoplasty. Ophthalmology. 1986; 93:1304-1309.
7. Epstein RJ, Stulting RD, Hendricks RL, et al. Corneal neovasculariza-tion. Pathogenesis and inhibition. Cornea. 1987;6:250-257.
8. Pillai CT, Dua HS, Hossain P. Fine needle diathermy occlusion of corneal vessels. Invest Ophthalmol Vis Sci. 2000;41:2148-2153.
9. Faraj LA, Elalfy MS, Said DG, et al. Fine needle diathermy occlusion of corneal vessels. Br J Ophthalmol. 2014;98:1287-1290.
10. Wertheim MS, Cook SD, Knox-Cartwright NE, et al. Electrolysis-needle cauterization of corneal vessels in patients with lipid keratopathy. Cornea. 2007;26:230-231.
11. Yeung SN, Lichtinger A, Kim P, et al. Combined use of subconjunctival and intracorneal bevacizumab injection for corneal neovascularization. Cornea. 2011;30:1110-1114.
12. Chang JH, Garg NK, Lunde E, et al. Corneal neovascularization: an anti-VEGF therapy review. Surv Ophthalmol. 2012;57:415-429.
13. Koenig Y, Bock F, Kruse FE, et al. Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs. Cornea. 2012;31:887-892.
14. Lueder GT, Culican S. Yellow dye laser treatment of vascularized corneal stromal scars in pediatric patients. Arch Ophthalmol. 2008;126: 564-566.
15. Cursiefen C, Hofmann-Rummelt C, Kuchle M, et al. Pericyte recruitment in human corneal angiogenesis: an ultrastructural study with clinico-pathological correlation. Br J Ophthalmol. 2003;87:101-106.
16. Junghans BM, Collin HB. The limbal vascular response to corneal injury. An autoradiographic study. Cornea. 1989;8:141-149.
17. Papathanassiou M, Theodoropoulou S, Analitis A, et al. Vascular endothelial growth factor inhibitors for treatment of corneal neovascula-rization: a meta-analysis. Cornea. 2013;32:435-444.
18. Oh JY, Kim MK, Wee WR. Subconjunctival and intracorneal bevacizu-mab injection for corneal neovascularization in lipid keratopathy. Cornea. 2009;28:1070-1073.
19. Hashemian MN, Zare MA, Rahimi F, et al. Deep intrastromal bevacizumab injection for management of corneal stromal vasculariza-tion after deep anterior lamellar keratoplasty, a novel technique. Cornea. 2011;30:215-218.
20. Mohammadpour M. Deep intrastromal injection of bevacizumab for the management of corneal neovascularization. Cornea. 2013;32:109-110.
21. Trikha S, Parikh S, Osmond C, et al. Long-term outcomes of Fine Needle Diathermy for established corneal neovascularisation. Br J Ophthalmol. 2014;98:454-458.
22. Dastjerdi MH, Sadrai Z, Saban DR, et al. Corneal penetration of topical and subconjunctival bevacizumab. Invest Ophthalmol Vis Sci. 2011;52: 8718-8723.
23. Ferrari G, Hajrasouliha AR, Sadrai Z, et al. Nerves and neovessels inhibit each other in the cornea. Invest Ophthalmol Vis Sci. 2013;54: 813-820.
24. Kirwan RP, Zheng Y, Tey A, et al. Quantifying changes in corneal neovascularization using fluorescein and indocyanine green angiography. Am J Ophthalmol. 2012;154:850-858.